{"results": [{"id": "0001479290:2014:FY", "start_date": "2014-01-01", "end_date": "2014-12-31", "filing_date": "2015-03-04", "timeframe": "annual", "fiscal_period": "FY", "fiscal_year": "2014", "cik": "0001479290", "sic": "2834", "tickers": ["RVNC"], "company_name": "Revance Therapeutics, Inc.", "source_filing_url": "https://api.polygon.io/v1/reference/sec/filings/0001628280-15-001461", "source_filing_file_url": "http://api.polygon.io/v1/reference/sec/filings/0001628280-15-001461/files/rvnc-20141231.xml", "financials": {"balance_sheet": {"other_than_fixed_noncurrent_assets": {"value": 464000, "unit": "USD", "label": "Other Than Fixed Noncurrent Assets", "order": 500}, "temporary_equity": {"value": 0, "unit": "USD", "label": "Temporary Equity", "order": 1700}, "current_liabilities": {"value": 10236000.0, "unit": "USD", "label": "Current Liabilities", "order": 700}, "liabilities": {"value": 16100000.0, "unit": "USD", "label": "Liabilities", "order": 600}, "liabilities_and_equity": {"value": 192469000.0, "unit": "USD", "label": "Liabilities And Equity", "order": 1900}, "current_assets": {"value": 172731000.0, "unit": "USD", "label": "Current Assets", "order": 200}, "equity_attributable_to_parent": {"value": 176369000.0, "unit": "USD", "label": "Equity Attributable To Parent", "order": 1600}, "noncurrent_liabilities": {"value": 5864000.0, "unit": "USD", "label": "Noncurrent Liabilities", "order": 800}, "equity": {"value": 176369000.0, "unit": "USD", "label": "Equity", "order": 1400}, "assets": {"value": 192469000.0, "unit": "USD", "label": "Assets", "order": 100}, "noncurrent_assets": {"value": 19738000.0, "unit": "USD", "label": "Noncurrent Assets", "order": 300}, "temporary_equity_attributable_to_parent": {"value": 0, "unit": "USD", "label": "Temporary Equity Attributable To Parent", "order": 1800}, "equity_attributable_to_noncontrolling_interest": {"value": 0, "unit": "USD", "label": "Equity Attributable To Noncontrolling Interest", "order": 1500}, "fixed_assets": {"value": 19274000.0, "unit": "USD", "label": "Fixed Assets", "order": 400}}, "comprehensive_income": {"other_comprehensive_income_loss": {"value": 0, "unit": "USD", "label": "Other Comprehensive Income/Loss", "order": 400}, "comprehensive_income_loss_attributable_to_noncontrolling_interest": {"value": 0, "unit": "USD", "label": "Comprehensive Income/Loss Attributable To Noncontrolling Interest", "order": 200}, "comprehensive_income_loss_attributable_to_parent": {"value": -62917000.0, "unit": "USD", "label": "Comprehensive Income/Loss Attributable To Parent", "order": 300}, "comprehensive_income_loss": {"value": -62917000.0, "unit": "USD", "label": "Comprehensive Income/Loss", "order": 100}}, "income_statement": {"net_income_loss_available_to_common_stockholders_basic": {"value": -62917000.0, "unit": "USD", "label": "Net Income/Loss Available To Common Stockholders, Basic", "order": 3700}, "undistributed_earnings_loss_allocated_to_participating_securities_basic": {"value": 0, "unit": "USD", "label": "Undistributed Earnings/Loss Allocated To Participating Securities, Basic", "order": 4100}, "net_income_loss_attributable_to_parent": {"value": -62917000.0, "unit": "USD", "label": "Net Income/Loss Attributable To Parent", "order": 3500}, "participating_securities_distributed_and_undistributed_earnings_loss_basic": {"value": 0, "unit": "USD", "label": "Participating Securities, Distributed And Undistributed Earnings/Loss, Basic", "order": 3800}, "costs_and_expenses": {"value": 52433000.0, "unit": "USD", "label": "Costs And Expenses", "order": 600}, "income_loss_from_continuing_operations_before_tax": {"value": 383000, "unit": "USD", "label": "Income/Loss From Continuing Operations Before Tax", "order": 1500}, "income_loss_from_continuing_operations_after_tax": {"value": -62917000.0, "unit": "USD", "label": "Income/Loss From Continuing Operations After Tax", "order": 1400}, "basic_earnings_per_share": {"value": -3.24, "unit": "USD / shares", "label": "Basic Earnings Per Share", "order": 4200}, "diluted_earnings_per_share": {"value": -3.24, "unit": "USD / shares", "label": "Diluted Earnings Per Share", "order": 4300}, "preferred_stock_dividends_and_other_adjustments": {"value": 0, "unit": "USD", "label": "Preferred Stock Dividends And Other Adjustments", "order": 3900}, "revenues": {"value": 383000, "unit": "USD", "label": "Revenues", "order": 100}, "operating_income_loss": {"value": -52050000.0, "unit": "USD", "label": "Operating Income/Loss", "order": 1100}, "operating_expenses": {"value": 52433000.0, "unit": "USD", "label": "Operating Expenses", "order": 1000}, "net_income_loss_attributable_to_noncontrolling_interest": {"value": 0, "unit": "USD", "label": "Net Income/Loss Attributable To Noncontrolling Interest", "order": 3300}, "net_income_loss": {"value": -62917000.0, "unit": "USD", "label": "Net Income/Loss", "order": 3200}, "benefits_costs_expenses": {"value": 0, "unit": "USD", "label": "Benefits Costs and Expenses", "order": 200}, "interest_expense_operating": {"value": 10672000.0, "unit": "USD", "label": "Interest Expense, Operating", "order": 2700}}, "cash_flow_statement": {"net_cash_flow_from_investing_activities_continuing": {"value": -6900000.0, "unit": "USD", "label": "Net Cash Flow From Investing Activities, Continuing", "order": 500}, "net_cash_flow": {"value": 167118000.0, "unit": "USD", "label": "Net Cash Flow", "order": 1100}, "net_cash_flow_from_operating_activities_continuing": {"value": -55073000.0, "unit": "USD", "label": "Net Cash Flow From Operating Activities, Continuing", "order": 200}, "net_cash_flow_from_investing_activities": {"value": -6900000.0, "unit": "USD", "label": "Net Cash Flow From Investing Activities", "order": 400}, "net_cash_flow_continuing": {"value": 167118000.0, "unit": "USD", "label": "Net Cash Flow, Continuing", "order": 1200}, "net_cash_flow_from_operating_activities": {"value": -55073000.0, "unit": "USD", "label": "Net Cash Flow From Operating Activities", "order": 100}, "net_cash_flow_from_financing_activities": {"value": 229091000.0, "unit": "USD", "label": "Net Cash Flow From Financing Activities", "order": 700}, "net_cash_flow_from_financing_activities_continuing": {"value": 229091000.0, "unit": "USD", "label": "Net Cash Flow From Financing Activities, Continuing", "order": 800}}}}, {"id": "0001479290:2015:FY", "start_date": "2015-01-01", "end_date": "2015-12-31", "filing_date": "2016-03-04", "timeframe": "annual", "fiscal_period": "FY", "fiscal_year": "2015", "cik": "0001479290", "sic": "2834", "tickers": ["RVNC"], "company_name": "Revance Therapeutics, Inc.", "source_filing_url": "https://api.polygon.io/v1/reference/sec/filings/0001479290-16-000031", "source_filing_file_url": "http://api.polygon.io/v1/reference/sec/filings/0001479290-16-000031/files/rvnc-20151231.xml", "financials": {"balance_sheet": {"liabilities": {"value": 22570000.0, "unit": "USD", "label": "Liabilities", "order": 600}, "fixed_assets": {"value": 19708000.0, "unit": "USD", "label": "Fixed Assets", "order": 400}, "temporary_equity_attributable_to_parent": {"value": 0, "unit": "USD", "label": "Temporary Equity Attributable To Parent", "order": 1800}, "equity": {"value": 253252000.0, "unit": "USD", "label": "Equity", "order": 1400}, "equity_attributable_to_parent": {"value": 253252000.0, "unit": "USD", "label": "Equity Attributable To Parent", "order": 1600}, "current_liabilities": {"value": 12037000.0, "unit": "USD", "label": "Current Liabilities", "order": 700}, "noncurrent_assets": {"value": 21859000.0, "unit": "USD", "label": "Noncurrent Assets", "order": 300}, "temporary_equity": {"value": 0, "unit": "USD", "label": "Temporary Equity", "order": 1700}, "current_assets": {"value": 253963000.0, "unit": "USD", "label": "Current Assets", "order": 200}, "other_than_fixed_noncurrent_assets": {"value": 2151000.0, "unit": "USD", "label": "Other Than Fixed Noncurrent Assets", "order": 500}, "assets": {"value": 275822000.0, "unit": "USD", "label": "Assets", "order": 100}, "noncurrent_liabilities": {"value": 10533000.0, "unit": "USD", "label": "Noncurrent Liabilities", "order": 800}, "liabilities_and_equity": {"value": 275822000.0, "unit": "USD", "label": "Liabilities And Equity", "order": 1900}, "equity_attributable_to_noncontrolling_interest": {"value": 0, "unit": "USD", "label": "Equity Attributable To Noncontrolling Interest", "order": 1500}}, "income_statement": {"net_income_loss_available_to_common_stockholders_basic": {"value": -73476000.0, "unit": "USD", "label": "Net Income/Loss Available To Common Stockholders, Basic", "order": 3700}, "income_loss_from_continuing_operations_after_tax": {"value": -73500000.0, "unit": "USD", "label": "Income/Loss From Continuing Operations After Tax", "order": 1400}, "operating_income_loss": {"value": -72317000.0, "unit": "USD", "label": "Operating Income/Loss", "order": 1100}, "revenues": {"value": 300000, "unit": "USD", "label": "Revenues", "order": 100}, "net_income_loss": {"value": -73500000.0, "unit": "USD", "label": "Net Income/Loss", "order": 3200}, "diluted_earnings_per_share": {"value": -3.02, "unit": "USD / shares", "label": "Diluted Earnings Per Share", "order": 4300}, "net_income_loss_attributable_to_noncontrolling_interest": {"value": 0, "unit": "USD", "label": "Net Income/Loss Attributable To Noncontrolling Interest", "order": 3300}, "benefits_costs_expenses": {"value": 0, "unit": "USD", "label": "Benefits Costs and Expenses", "order": 200}, "participating_securities_distributed_and_undistributed_earnings_loss_basic": {"value": -24000, "unit": "USD", "label": "Participating Securities, Distributed And Undistributed Earnings/Loss, Basic", "order": 3800}, "preferred_stock_dividends_and_other_adjustments": {"value": -24000, "unit": "USD", "label": "Preferred Stock Dividends And Other Adjustments", "order": 3900}, "costs_and_expenses": {"value": 72617000.0, "unit": "USD", "label": "Costs And Expenses", "order": 600}, "undistributed_earnings_loss_allocated_to_participating_securities_basic": {"value": 0, "unit": "USD", "label": "Undistributed Earnings/Loss Allocated To Participating Securities, Basic", "order": 4100}, "interest_expense_operating": {"value": 1190000.0, "unit": "USD", "label": "Interest Expense, Operating", "order": 2700}, "net_income_loss_attributable_to_parent": {"value": -73500000.0, "unit": "USD", "label": "Net Income/Loss Attributable To Parent", "order": 3500}, "income_loss_from_continuing_operations_before_tax": {"value": 300000, "unit": "USD", "label": "Income/Loss From Continuing Operations Before Tax", "order": 1500}, "basic_earnings_per_share": {"value": -3.02, "unit": "USD / shares", "label": "Basic Earnings Per Share", "order": 4200}, "operating_expenses": {"value": 72617000.0, "unit": "USD", "label": "Operating Expenses", "order": 1000}}, "cash_flow_statement": {"net_cash_flow_from_investing_activities_continuing": {"value": -56340000.0, "unit": "USD", "label": "Net Cash Flow From Investing Activities, Continuing", "order": 500}, "net_cash_flow_from_financing_activities": {"value": 142592000.0, "unit": "USD", "label": "Net Cash Flow From Financing Activities", "order": 700}, "net_cash_flow_from_operating_activities_continuing": {"value": -55669000.0, "unit": "USD", "label": "Net Cash Flow From Operating Activities, Continuing", "order": 200}, "net_cash_flow_from_financing_activities_continuing": {"value": 142592000.0, "unit": "USD", "label": "Net Cash Flow From Financing Activities, Continuing", "order": 800}, "net_cash_flow_from_operating_activities": {"value": -55669000.0, "unit": "USD", "label": "Net Cash Flow From Operating Activities", "order": 100}, "net_cash_flow_from_investing_activities": {"value": -56340000.0, "unit": "USD", "label": "Net Cash Flow From Investing Activities", "order": 400}, "net_cash_flow_continuing": {"value": 30583000.0, "unit": "USD", "label": "Net Cash Flow, Continuing", "order": 1200}, "net_cash_flow": {"value": 30583000.0, "unit": "USD", "label": "Net Cash Flow", "order": 1100}}, "comprehensive_income": {"other_comprehensive_income_loss": {"value": -73516000.0, "unit": "USD", "label": "Other Comprehensive Income/Loss", "order": 400}, "comprehensive_income_loss_attributable_to_parent": {"value": -73516000.0, "unit": "USD", "label": "Comprehensive Income/Loss Attributable To Parent", "order": 300}, "comprehensive_income_loss": {"value": -73516000.0, "unit": "USD", "label": "Comprehensive Income/Loss", "order": 100}, "comprehensive_income_loss_attributable_to_noncontrolling_interest": {"value": 0, "unit": "USD", "label": "Comprehensive Income/Loss Attributable To Noncontrolling Interest", "order": 200}}}}, {"id": "0001479290:2016:FY", "start_date": "2016-01-01", "end_date": "2016-12-31", "filing_date": "2017-02-28", "timeframe": "annual", "fiscal_period": "FY", "fiscal_year": "2016", "cik": "0001479290", "sic": "2834", "tickers": ["RVNC"], "company_name": "Revance Therapeutics, Inc.", "source_filing_url": "https://api.polygon.io/v1/reference/sec/filings/0001479290-17-000013", "source_filing_file_url": "http://api.polygon.io/v1/reference/sec/filings/0001479290-17-000013/files/rvnc-20161231.xml", "financials": {"balance_sheet": {"equity": {"value": 177071000.0, "unit": "USD", "label": "Equity", "order": 1400}, "current_assets": {"value": 192695000.0, "unit": "USD", "label": "Current Assets", "order": 200}, "liabilities_and_equity": {"value": 204360000.0, "unit": "USD", "label": "Liabilities And Equity", "order": 1900}, "equity_attributable_to_noncontrolling_interest": {"value": 0, "unit": "USD", "label": "Equity Attributable To Noncontrolling Interest", "order": 1500}, "equity_attributable_to_parent": {"value": 177071000.0, "unit": "USD", "label": "Equity Attributable To Parent", "order": 1600}, "other_than_fixed_noncurrent_assets": {"value": 1080000.0, "unit": "USD", "label": "Other Than Fixed Noncurrent Assets", "order": 500}, "noncurrent_liabilities": {"value": 7642000.0, "unit": "USD", "label": "Noncurrent Liabilities", "order": 800}, "fixed_assets": {"value": 10585000.0, "unit": "USD", "label": "Fixed Assets", "order": 400}, "noncurrent_assets": {"value": 11665000.0, "unit": "USD", "label": "Noncurrent Assets", "order": 300}, "temporary_equity": {"value": 0, "unit": "USD", "label": "Temporary Equity", "order": 1700}, "assets": {"value": 204360000.0, "unit": "USD", "label": "Assets", "order": 100}, "current_liabilities": {"value": 19647000.0, "unit": "USD", "label": "Current Liabilities", "order": 700}, "liabilities": {"value": 27289000.0, "unit": "USD", "label": "Liabilities", "order": 600}}, "comprehensive_income": {"other_comprehensive_income_loss": {"value": -89275000.0, "unit": "USD", "label": "Other Comprehensive Income/Loss", "order": 400}, "comprehensive_income_loss": {"value": -89275000.0, "unit": "USD", "label": "Comprehensive Income/Loss", "order": 100}, "comprehensive_income_loss_attributable_to_parent": {"value": -89275000.0, "unit": "USD", "label": "Comprehensive Income/Loss Attributable To Parent", "order": 300}, "comprehensive_income_loss_attributable_to_noncontrolling_interest": {"value": 0, "unit": "USD", "label": "Comprehensive Income/Loss Attributable To Noncontrolling Interest", "order": 200}}, "income_statement": {"net_income_loss_attributable_to_noncontrolling_interest": {"value": 0, "unit": "USD", "label": "Net Income/Loss Attributable To Noncontrolling Interest", "order": 3300}, "revenues": {"value": 300000, "unit": "USD", "label": "Revenues", "order": 100}, "operating_income_loss": {"value": -88215000.0, "unit": "USD", "label": "Operating Income/Loss", "order": 1100}, "net_income_loss": {"value": -89300000.0, "unit": "USD", "label": "Net Income/Loss", "order": 3200}, "benefits_costs_expenses": {"value": 0, "unit": "USD", "label": "Benefits Costs and Expenses", "order": 200}, "net_income_loss_available_to_common_stockholders_basic": {"value": -89300000.0, "unit": "USD", "label": "Net Income/Loss Available To Common Stockholders, Basic", "order": 3700}, "income_loss_from_continuing_operations_after_tax": {"value": -89300000.0, "unit": "USD", "label": "Income/Loss From Continuing Operations After Tax", "order": 1400}, "net_income_loss_attributable_to_parent": {"value": -89300000.0, "unit": "USD", "label": "Net Income/Loss Attributable To Parent", "order": 3500}, "interest_expense_operating": {"value": 1082000.0, "unit": "USD", "label": "Interest Expense, Operating", "order": 2700}, "operating_expenses": {"value": 88515000.0, "unit": "USD", "label": "Operating Expenses", "order": 1000}, "costs_and_expenses": {"value": 88515000.0, "unit": "USD", "label": "Costs And Expenses", "order": 600}, "participating_securities_distributed_and_undistributed_earnings_loss_basic": {"value": 0, "unit": "USD", "label": "Participating Securities, Distributed And Undistributed Earnings/Loss, Basic", "order": 3800}, "income_loss_from_continuing_operations_before_tax": {"value": 300000, "unit": "USD", "label": "Income/Loss From Continuing Operations Before Tax", "order": 1500}, "preferred_stock_dividends_and_other_adjustments": {"value": 0, "unit": "USD", "label": "Preferred Stock Dividends And Other Adjustments", "order": 3900}}, "cash_flow_statement": {"net_cash_flow_from_operating_activities_continuing": {"value": -59827000.0, "unit": "USD", "label": "Net Cash Flow From Operating Activities, Continuing", "order": 200}, "net_cash_flow_from_investing_activities_continuing": {"value": -75499000.0, "unit": "USD", "label": "Net Cash Flow From Investing Activities, Continuing", "order": 500}, "net_cash_flow_from_financing_activities_continuing": {"value": -2642000.0, "unit": "USD", "label": "Net Cash Flow From Financing Activities, Continuing", "order": 800}, "net_cash_flow_from_operating_activities": {"value": -59827000.0, "unit": "USD", "label": "Net Cash Flow From Operating Activities", "order": 100}, "net_cash_flow": {"value": -137968000.0, "unit": "USD", "label": "Net Cash Flow", "order": 1100}, "net_cash_flow_continuing": {"value": -137968000.0, "unit": "USD", "label": "Net Cash Flow, Continuing", "order": 1200}, "net_cash_flow_from_financing_activities": {"value": -2642000.0, "unit": "USD", "label": "Net Cash Flow From Financing Activities", "order": 700}, "net_cash_flow_from_investing_activities": {"value": -75499000.0, "unit": "USD", "label": "Net Cash Flow From Investing Activities", "order": 400}}}}, {"id": "0001479290:2017:FY", "start_date": "2017-01-01", "end_date": "2017-12-31", "filing_date": "2018-03-02", "timeframe": "annual", "fiscal_period": "FY", "fiscal_year": "2017", "cik": "0001479290", "sic": "2834", "tickers": ["RVNC"], "company_name": "Revance Therapeutics, Inc.", "source_filing_url": "https://api.polygon.io/v1/reference/sec/filings/0001479290-18-000038", "source_filing_file_url": "http://api.polygon.io/v1/reference/sec/filings/0001479290-18-000038/files/rvnc-20171231.xml", "financials": {"balance_sheet": {"equity": {"value": 268845000.0, "unit": "USD", "label": "Equity", "order": 1400}, "noncurrent_liabilities": {"value": 5952000.0, "unit": "USD", "label": "Noncurrent Liabilities", "order": 800}, "other_than_fixed_noncurrent_assets": {"value": 1238000.0, "unit": "USD", "label": "Other Than Fixed Noncurrent Assets", "order": 500}, "current_assets": {"value": 285211000.0, "unit": "USD", "label": "Current Assets", "order": 200}, "current_liabilities": {"value": 20902000.0, "unit": "USD", "label": "Current Liabilities", "order": 700}, "liabilities_and_equity": {"value": 295699000.0, "unit": "USD", "label": "Liabilities And Equity", "order": 1900}, "equity_attributable_to_parent": {"value": 268845000.0, "unit": "USD", "label": "Equity Attributable To Parent", "order": 1600}, "assets": {"value": 295699000.0, "unit": "USD", "label": "Assets", "order": 100}, "equity_attributable_to_noncontrolling_interest": {"value": 0, "unit": "USD", "label": "Equity Attributable To Noncontrolling Interest", "order": 1500}, "fixed_assets": {"value": 9250000.0, "unit": "USD", "label": "Fixed Assets", "order": 400}, "liabilities": {"value": 26854000.0, "unit": "USD", "label": "Liabilities", "order": 600}, "noncurrent_assets": {"value": 10488000.0, "unit": "USD", "label": "Noncurrent Assets", "order": 300}}, "cash_flow_statement": {"net_cash_flow_from_operating_activities": {"value": -95342000.0, "unit": "USD", "label": "Net Cash Flow From Operating Activities", "order": 100}, "net_cash_flow_continuing": {"value": 219394000.0, "unit": "USD", "label": "Net Cash Flow, Continuing", "order": 1200}, "net_cash_flow": {"value": 219394000.0, "unit": "USD", "label": "Net Cash Flow", "order": 1100}, "net_cash_flow_from_investing_activities_continuing": {"value": 118792000.0, "unit": "USD", "label": "Net Cash Flow From Investing Activities, Continuing", "order": 500}, "net_cash_flow_from_investing_activities": {"value": 118792000.0, "unit": "USD", "label": "Net Cash Flow From Investing Activities", "order": 400}, "net_cash_flow_from_financing_activities_continuing": {"value": 195944000.0, "unit": "USD", "label": "Net Cash Flow From Financing Activities, Continuing", "order": 800}, "net_cash_flow_from_financing_activities": {"value": 195944000.0, "unit": "USD", "label": "Net Cash Flow From Financing Activities", "order": 700}, "net_cash_flow_from_operating_activities_continuing": {"value": -95342000.0, "unit": "USD", "label": "Net Cash Flow From Operating Activities, Continuing", "order": 200}}, "comprehensive_income": {"comprehensive_income_loss_attributable_to_noncontrolling_interest": {"value": 0, "unit": "USD", "label": "Comprehensive Income/Loss Attributable To Noncontrolling Interest", "order": 200}, "other_comprehensive_income_loss": {"value": -120542000.0, "unit": "USD", "label": "Other Comprehensive Income/Loss", "order": 400}, "comprehensive_income_loss": {"value": -120542000.0, "unit": "USD", "label": "Comprehensive Income/Loss", "order": 100}, "comprehensive_income_loss_attributable_to_parent": {"value": -120542000.0, "unit": "USD", "label": "Comprehensive Income/Loss Attributable To Parent", "order": 300}}, "income_statement": {"net_income_loss_attributable_to_parent": {"value": -120587000.0, "unit": "USD", "label": "Net Income/Loss Attributable To Parent", "order": 3500}, "participating_securities_distributed_and_undistributed_earnings_loss_basic": {"value": 0, "unit": "USD", "label": "Participating Securities, Distributed And Undistributed Earnings/Loss, Basic", "order": 3800}, "preferred_stock_dividends_and_other_adjustments": {"value": 0, "unit": "USD", "label": "Preferred Stock Dividends And Other Adjustments", "order": 3900}, "net_income_loss_attributable_to_noncontrolling_interest": {"value": 0, "unit": "USD", "label": "Net Income/Loss Attributable To Noncontrolling Interest", "order": 3300}, "income_loss_from_continuing_operations_after_tax": {"value": -120587000.0, "unit": "USD", "label": "Income/Loss From Continuing Operations After Tax", "order": 1400}, "interest_expense_operating": {"value": 457000, "unit": "USD", "label": "Interest Expense, Operating", "order": 2700}, "revenues": {"value": 262000, "unit": "USD", "label": "Revenues", "order": 100}, "income_loss_from_continuing_operations_before_tax": {"value": -120587000.0, "unit": "USD", "label": "Income/Loss From Continuing Operations Before Tax", "order": 1500}, "operating_expenses": {"value": 120686000.0, "unit": "USD", "label": "Operating Expenses", "order": 1000}, "net_income_loss": {"value": -120587000.0, "unit": "USD", "label": "Net Income/Loss", "order": 3200}, "operating_income_loss": {"value": -120424000.0, "unit": "USD", "label": "Operating Income/Loss", "order": 1100}, "income_loss_before_equity_method_investments": {"value": -120587000.0, "unit": "USD", "label": "Income/Loss Before Equity Method Investments", "order": 1300}, "net_income_loss_available_to_common_stockholders_basic": {"value": -120587000.0, "unit": "USD", "label": "Net Income/Loss Available To Common Stockholders, Basic", "order": 3700}, "costs_and_expenses": {"value": 120849000.0, "unit": "USD", "label": "Costs And Expenses", "order": 600}, "benefits_costs_expenses": {"value": 120849000.0, "unit": "USD", "label": "Benefits Costs and Expenses", "order": 200}}}}, {"id": "0001479290:2018:FY", "start_date": "2018-01-01", "end_date": "2018-12-31", "filing_date": "2019-02-28", "timeframe": "annual", "fiscal_period": "FY", "fiscal_year": "2018", "cik": "0001479290", "sic": "2834", "tickers": ["RVNC"], "company_name": "Revance Therapeutics, Inc.", "source_filing_url": "https://api.polygon.io/v1/reference/sec/filings/0001479290-19-000030", "source_filing_file_url": "http://api.polygon.io/v1/reference/sec/filings/0001479290-19-000030/files/rvnc1231201810k_htm.xml", "financials": {"comprehensive_income": {"other_comprehensive_income_loss": {"value": -142576000.0, "unit": "USD", "label": "Other Comprehensive Income/Loss", "order": 400}, "comprehensive_income_loss_attributable_to_parent": {"value": -142576000.0, "unit": "USD", "label": "Comprehensive Income/Loss Attributable To Parent", "order": 300}, "comprehensive_income_loss": {"value": -142576000.0, "unit": "USD", "label": "Comprehensive Income/Loss", "order": 100}, "comprehensive_income_loss_attributable_to_noncontrolling_interest": {"value": 0, "unit": "USD", "label": "Comprehensive Income/Loss Attributable To Noncontrolling Interest", "order": 200}}, "income_statement": {"net_income_loss": {"value": -142568000.0, "unit": "USD", "label": "Net Income/Loss", "order": 3200}, "costs_and_expenses": {"value": 146363000.0, "unit": "USD", "label": "Costs And Expenses", "order": 600}, "net_income_loss_attributable_to_parent": {"value": -142568000.0, "unit": "USD", "label": "Net Income/Loss Attributable To Parent", "order": 3500}, "preferred_stock_dividends_and_other_adjustments": {"value": 0, "unit": "USD", "label": "Preferred Stock Dividends And Other Adjustments", "order": 3900}, "net_income_loss_available_to_common_stockholders_basic": {"value": -142568000.0, "unit": "USD", "label": "Net Income/Loss Available To Common Stockholders, Basic", "order": 3700}, "income_tax_expense_benefit": {"value": 3000000.0, "unit": "USD", "label": "Income Tax Expense/Benefit", "order": 2200}, "net_income_loss_attributable_to_noncontrolling_interest": {"value": 0, "unit": "USD", "label": "Net Income/Loss Attributable To Noncontrolling Interest", "order": 3300}, "interest_expense_operating": {"value": 44000, "unit": "USD", "label": "Interest Expense, Operating", "order": 2700}, "operating_expenses": {"value": 146363000.0, "unit": "USD", "label": "Operating Expenses", "order": 1000}, "income_loss_from_continuing_operations_after_tax": {"value": -142568000.0, "unit": "USD", "label": "Income/Loss From Continuing Operations After Tax", "order": 1400}, "income_loss_from_continuing_operations_before_tax": {"value": 3729000.0, "unit": "USD", "label": "Income/Loss From Continuing Operations Before Tax", "order": 1500}, "participating_securities_distributed_and_undistributed_earnings_loss_basic": {"value": 0, "unit": "USD", "label": "Participating Securities, Distributed And Undistributed Earnings/Loss, Basic", "order": 3800}, "operating_income_loss": {"value": -142634000.0, "unit": "USD", "label": "Operating Income/Loss", "order": 1100}, "revenues": {"value": 3729000.0, "unit": "USD", "label": "Revenues", "order": 100}, "benefits_costs_expenses": {"value": 0, "unit": "USD", "label": "Benefits Costs and Expenses", "order": 200}}, "cash_flow_statement": {"net_cash_flow_from_investing_activities": {"value": -107026000.0, "unit": "USD", "label": "Net Cash Flow From Investing Activities", "order": 400}, "net_cash_flow_from_investing_activities_continuing": {"value": -107026000.0, "unit": "USD", "label": "Net Cash Flow From Investing Activities, Continuing", "order": 500}, "net_cash_flow_continuing": {"value": -209490000.0, "unit": "USD", "label": "Net Cash Flow, Continuing", "order": 1200}, "net_cash_flow": {"value": -209490000.0, "unit": "USD", "label": "Net Cash Flow", "order": 1100}, "net_cash_flow_from_operating_activities_continuing": {"value": -104246000.0, "unit": "USD", "label": "Net Cash Flow From Operating Activities, Continuing", "order": 200}, "net_cash_flow_from_financing_activities_continuing": {"value": 1782000.0, "unit": "USD", "label": "Net Cash Flow From Financing Activities, Continuing", "order": 800}, "net_cash_flow_from_financing_activities": {"value": 1782000.0, "unit": "USD", "label": "Net Cash Flow From Financing Activities", "order": 700}, "net_cash_flow_from_operating_activities": {"value": -104246000.0, "unit": "USD", "label": "Net Cash Flow From Operating Activities", "order": 100}}, "balance_sheet": {"current_assets": {"value": 207922000.0, "unit": "USD", "label": "Current Assets", "order": 200}, "equity": {"value": 145622000.0, "unit": "USD", "label": "Equity", "order": 1400}, "noncurrent_assets": {"value": 18426000.0, "unit": "USD", "label": "Noncurrent Assets", "order": 300}, "other_than_fixed_noncurrent_assets": {"value": 3977000.0, "unit": "USD", "label": "Other Than Fixed Noncurrent Assets", "order": 500}, "fixed_assets": {"value": 14449000.0, "unit": "USD", "label": "Fixed Assets", "order": 400}, "current_liabilities": {"value": 31970000.0, "unit": "USD", "label": "Current Liabilities", "order": 700}, "liabilities_and_equity": {"value": 226348000.0, "unit": "USD", "label": "Liabilities And Equity", "order": 1900}, "assets": {"value": 226348000.0, "unit": "USD", "label": "Assets", "order": 100}, "equity_attributable_to_noncontrolling_interest": {"value": 0, "unit": "USD", "label": "Equity Attributable To Noncontrolling Interest", "order": 1500}, "equity_attributable_to_parent": {"value": 145622000.0, "unit": "USD", "label": "Equity Attributable To Parent", "order": 1600}, "noncurrent_liabilities": {"value": 48756000.0, "unit": "USD", "label": "Noncurrent Liabilities", "order": 800}, "liabilities": {"value": 80726000.0, "unit": "USD", "label": "Liabilities", "order": 600}}}}, {"id": "0001479290:2019:FY", "start_date": "2019-01-01", "end_date": "2019-12-31", "filing_date": "2020-02-26", "timeframe": "annual", "fiscal_period": "FY", "fiscal_year": "2019", "cik": "0001479290", "sic": "2834", "tickers": ["RVNC"], "company_name": "Revance Therapeutics, Inc.", "source_filing_url": "https://api.polygon.io/v1/reference/sec/filings/0001479290-20-000042", "source_filing_file_url": "http://api.polygon.io/v1/reference/sec/filings/0001479290-20-000042/files/rvnc1231201910-k_htm.xml", "financials": {"balance_sheet": {"current_assets": {"value": 296602000.0, "unit": "USD", "label": "Current Assets", "order": 200}, "fixed_assets": {"value": 14755000.0, "unit": "USD", "label": "Fixed Assets", "order": 400}, "noncurrent_assets": {"value": 43685000.0, "unit": "USD", "label": "Noncurrent Assets", "order": 300}, "current_liabilities": {"value": 40979000.0, "unit": "USD", "label": "Current Liabilities", "order": 700}, "other_than_fixed_noncurrent_assets": {"value": 28930000.0, "unit": "USD", "label": "Other Than Fixed Noncurrent Assets", "order": 500}, "liabilities_and_equity": {"value": 340287000.0, "unit": "USD", "label": "Liabilities And Equity", "order": 1900}, "assets": {"value": 340287000.0, "unit": "USD", "label": "Assets", "order": 100}, "equity_attributable_to_parent": {"value": 225490000.0, "unit": "USD", "label": "Equity Attributable To Parent", "order": 1600}, "noncurrent_liabilities": {"value": 73818000.0, "unit": "USD", "label": "Noncurrent Liabilities", "order": 800}, "equity": {"value": 225490000.0, "unit": "USD", "label": "Equity", "order": 1400}, "liabilities": {"value": 114797000.0, "unit": "USD", "label": "Liabilities", "order": 600}, "equity_attributable_to_noncontrolling_interest": {"value": 0, "unit": "USD", "label": "Equity Attributable To Noncontrolling Interest", "order": 1500}}, "cash_flow_statement": {"net_cash_flow_continuing": {"value": 97904000.0, "unit": "USD", "label": "Net Cash Flow, Continuing", "order": 1200}, "net_cash_flow": {"value": 97904000.0, "unit": "USD", "label": "Net Cash Flow", "order": 1100}, "net_cash_flow_from_financing_activities_continuing": {"value": 221657000.0, "unit": "USD", "label": "Net Cash Flow From Financing Activities, Continuing", "order": 800}, "net_cash_flow_from_financing_activities": {"value": 221657000.0, "unit": "USD", "label": "Net Cash Flow From Financing Activities", "order": 700}, "net_cash_flow_from_investing_activities": {"value": -17592000.0, "unit": "USD", "label": "Net Cash Flow From Investing Activities", "order": 400}, "net_cash_flow_from_investing_activities_continuing": {"value": -17592000.0, "unit": "USD", "label": "Net Cash Flow From Investing Activities, Continuing", "order": 500}, "net_cash_flow_from_operating_activities_continuing": {"value": -106161000.0, "unit": "USD", "label": "Net Cash Flow From Operating Activities, Continuing", "order": 200}, "net_cash_flow_from_operating_activities": {"value": -106161000.0, "unit": "USD", "label": "Net Cash Flow From Operating Activities", "order": 100}}, "comprehensive_income": {"comprehensive_income_loss_attributable_to_noncontrolling_interest": {"value": 0, "unit": "USD", "label": "Comprehensive Income/Loss Attributable To Noncontrolling Interest", "order": 200}, "comprehensive_income_loss": {"value": -159418000.0, "unit": "USD", "label": "Comprehensive Income/Loss", "order": 100}, "comprehensive_income_loss_attributable_to_parent": {"value": -159418000.0, "unit": "USD", "label": "Comprehensive Income/Loss Attributable To Parent", "order": 300}, "other_comprehensive_income_loss": {"value": -159418000.0, "unit": "USD", "label": "Other Comprehensive Income/Loss", "order": 400}}, "income_statement": {"revenues": {"value": 413000, "unit": "USD", "label": "Revenues", "order": 100}, "net_income_loss_attributable_to_noncontrolling_interest": {"value": 0, "unit": "USD", "label": "Net Income/Loss Attributable To Noncontrolling Interest", "order": 3300}, "net_income_loss": {"value": -159429000.0, "unit": "USD", "label": "Net Income/Loss", "order": 3200}, "income_loss_from_continuing_operations_before_tax": {"value": 413000, "unit": "USD", "label": "Income/Loss From Continuing Operations Before Tax", "order": 1500}, "preferred_stock_dividends_and_other_adjustments": {"value": 0, "unit": "USD", "label": "Preferred Stock Dividends And Other Adjustments", "order": 3900}, "operating_expenses": {"value": 164872000.0, "unit": "USD", "label": "Operating Expenses", "order": 1000}, "net_income_loss_available_to_common_stockholders_basic": {"value": -159429000.0, "unit": "USD", "label": "Net Income/Loss Available To Common Stockholders, Basic", "order": 3700}, "net_income_loss_attributable_to_parent": {"value": -159429000.0, "unit": "USD", "label": "Net Income/Loss Attributable To Parent", "order": 3500}, "income_tax_expense_benefit": {"value": 0, "unit": "USD", "label": "Income Tax Expense/Benefit", "order": 2200}, "participating_securities_distributed_and_undistributed_earnings_loss_basic": {"value": 0, "unit": "USD", "label": "Participating Securities, Distributed And Undistributed Earnings/Loss, Basic", "order": 3800}, "operating_income_loss": {"value": -164459000.0, "unit": "USD", "label": "Operating Income/Loss", "order": 1100}, "benefits_costs_expenses": {"value": 0, "unit": "USD", "label": "Benefits Costs and Expenses", "order": 200}, "income_loss_from_continuing_operations_after_tax": {"value": -159429000.0, "unit": "USD", "label": "Income/Loss From Continuing Operations After Tax", "order": 1400}, "costs_and_expenses": {"value": 164872000.0, "unit": "USD", "label": "Costs And Expenses", "order": 600}, "interest_expense_operating": {"value": 0, "unit": "USD", "label": "Interest Expense, Operating", "order": 2700}}}}, {"id": "0001479290:2020:FY", "start_date": "2020-01-01", "end_date": "2020-12-31", "filing_date": "2021-02-25", "timeframe": "annual", "fiscal_period": "FY", "fiscal_year": "2020", "cik": "0001479290", "sic": "2834", "tickers": ["RVNC"], "company_name": "Revance Therapeutics, Inc.", "source_filing_url": "https://api.polygon.io/v1/reference/sec/filings/0001479290-21-000057", "source_filing_file_url": "http://api.polygon.io/v1/reference/sec/filings/0001479290-21-000057/files/rvnc-20201231_htm.xml", "financials": {"cash_flow_statement": {"net_cash_flow": {"value": 165113000.0, "unit": "USD", "label": "Net Cash Flow", "order": 1100}, "net_cash_flow_from_investing_activities": {"value": 12131000.0, "unit": "USD", "label": "Net Cash Flow From Investing Activities", "order": 400}, "net_cash_flow_continuing": {"value": 165113000.0, "unit": "USD", "label": "Net Cash Flow, Continuing", "order": 1200}, "net_cash_flow_from_investing_activities_continuing": {"value": 12131000.0, "unit": "USD", "label": "Net Cash Flow From Investing Activities, Continuing", "order": 500}, "net_cash_flow_from_financing_activities_continuing": {"value": 331484000.0, "unit": "USD", "label": "Net Cash Flow From Financing Activities, Continuing", "order": 800}, "net_cash_flow_from_operating_activities": {"value": -178502000.0, "unit": "USD", "label": "Net Cash Flow From Operating Activities", "order": 100}, "net_cash_flow_from_financing_activities": {"value": 331484000.0, "unit": "USD", "label": "Net Cash Flow From Financing Activities", "order": 700}, "net_cash_flow_from_operating_activities_continuing": {"value": -178502000.0, "unit": "USD", "label": "Net Cash Flow From Operating Activities, Continuing", "order": 200}}, "comprehensive_income": {"comprehensive_income_loss": {"value": -282092000.0, "unit": "USD", "label": "Comprehensive Income/Loss", "order": 100}, "other_comprehensive_income_loss": {"value": -282092000.0, "unit": "USD", "label": "Other Comprehensive Income/Loss", "order": 400}, "comprehensive_income_loss_attributable_to_parent": {"value": -282092000.0, "unit": "USD", "label": "Comprehensive Income/Loss Attributable To Parent", "order": 300}, "comprehensive_income_loss_attributable_to_noncontrolling_interest": {"value": 0, "unit": "USD", "label": "Comprehensive Income/Loss Attributable To Noncontrolling Interest", "order": 200}}, "balance_sheet": {"liabilities_and_equity": {"value": 720220000.0, "unit": "USD", "label": "Liabilities And Equity", "order": 1900}, "liabilities": {"value": 345930000.0, "unit": "USD", "label": "Liabilities", "order": 600}, "equity_attributable_to_parent": {"value": 374290000.0, "unit": "USD", "label": "Equity Attributable To Parent", "order": 1600}, "current_liabilities": {"value": 60964000.0, "unit": "USD", "label": "Current Liabilities", "order": 700}, "noncurrent_liabilities": {"value": 284966000.0, "unit": "USD", "label": "Noncurrent Liabilities", "order": 800}, "equity_attributable_to_noncontrolling_interest": {"value": 0, "unit": "USD", "label": "Equity Attributable To Noncontrolling Interest", "order": 1500}, "fixed_assets": {"value": 17499000.0, "unit": "USD", "label": "Fixed Assets", "order": 400}, "assets": {"value": 720220000.0, "unit": "USD", "label": "Assets", "order": 100}, "other_than_fixed_noncurrent_assets": {"value": 252718000.0, "unit": "USD", "label": "Other Than Fixed Noncurrent Assets", "order": 500}, "current_assets": {"value": 450003000.0, "unit": "USD", "label": "Current Assets", "order": 200}, "noncurrent_assets": {"value": 270217000.0, "unit": "USD", "label": "Noncurrent Assets", "order": 300}, "equity": {"value": 374290000.0, "unit": "USD", "label": "Equity", "order": 1400}}, "income_statement": {"income_tax_expense_benefit": {"value": -2620000.0, "unit": "USD", "label": "Income Tax Expense/Benefit", "order": 2200}, "net_income_loss_attributable_to_noncontrolling_interest": {"value": 0, "unit": "USD", "label": "Net Income/Loss Attributable To Noncontrolling Interest", "order": 3300}, "costs_and_expenses": {"value": 288487000.0, "unit": "USD", "label": "Costs And Expenses", "order": 600}, "income_tax_expense_benefit_deferred": {"value": -2720000.0, "unit": "USD", "label": "Income Tax Expense/Benefit, Deferred", "order": 2400}, "operating_income_loss": {"value": -273162000.0, "unit": "USD", "label": "Operating Income/Loss", "order": 1100}, "income_loss_from_continuing_operations_after_tax": {"value": -282089000.0, "unit": "USD", "label": "Income/Loss From Continuing Operations After Tax", "order": 1400}, "revenues": {"value": 15325000.0, "unit": "USD", "label": "Revenues", "order": 100}, "net_income_loss": {"value": -282089000.0, "unit": "USD", "label": "Net Income/Loss", "order": 3200}, "income_tax_expense_benefit_current": {"value": 100000, "unit": "USD", "label": "Income Tax Expense/Benefit, Current", "order": 2300}, "preferred_stock_dividends_and_other_adjustments": {"value": 0, "unit": "USD", "label": "Preferred Stock Dividends And Other Adjustments", "order": 3900}, "net_income_loss_attributable_to_parent": {"value": -282089000.0, "unit": "USD", "label": "Net Income/Loss Attributable To Parent", "order": 3500}, "benefits_costs_expenses": {"value": 0, "unit": "USD", "label": "Benefits Costs and Expenses", "order": 200}, "operating_expenses": {"value": 288487000.0, "unit": "USD", "label": "Operating Expenses", "order": 1000}, "income_loss_from_continuing_operations_before_tax": {"value": 15325000.0, "unit": "USD", "label": "Income/Loss From Continuing Operations Before Tax", "order": 1500}, "participating_securities_distributed_and_undistributed_earnings_loss_basic": {"value": 0, "unit": "USD", "label": "Participating Securities, Distributed And Undistributed Earnings/Loss, Basic", "order": 3800}, "interest_expense_operating": {"value": 15148000.0, "unit": "USD", "label": "Interest Expense, Operating", "order": 2700}, "net_income_loss_available_to_common_stockholders_basic": {"value": -282089000.0, "unit": "USD", "label": "Net Income/Loss Available To Common Stockholders, Basic", "order": 3700}}}}, {"id": "0001479290:2021:FY", "start_date": "2021-01-01", "end_date": "2021-12-31", "filing_date": "2022-02-28", "timeframe": "annual", "fiscal_period": "FY", "fiscal_year": "2021", "cik": "0001479290", "sic": "2834", "tickers": ["RVNC"], "company_name": "Revance Therapeutics, Inc.", "source_filing_url": "https://api.polygon.io/v1/reference/sec/filings/0001479290-22-000034", "source_filing_file_url": "http://api.polygon.io/v1/reference/sec/filings/0001479290-22-000034/files/rvnc-20211231_htm.xml", "financials": {"cash_flow_statement": {"net_cash_flow_from_financing_activities_continuing": {"value": 29869000.0, "unit": "USD", "label": "Net Cash Flow From Financing Activities, Continuing", "order": 800}, "net_cash_flow_from_financing_activities": {"value": 29869000.0, "unit": "USD", "label": "Net Cash Flow From Financing Activities", "order": 700}, "net_cash_flow_from_operating_activities": {"value": -221538000.0, "unit": "USD", "label": "Net Cash Flow From Operating Activities", "order": 100}, "net_cash_flow_from_investing_activities": {"value": -29665000.0, "unit": "USD", "label": "Net Cash Flow From Investing Activities", "order": 400}, "net_cash_flow": {"value": -221334000.0, "unit": "USD", "label": "Net Cash Flow", "order": 1100}, "net_cash_flow_from_operating_activities_continuing": {"value": -221538000.0, "unit": "USD", "label": "Net Cash Flow From Operating Activities, Continuing", "order": 200}, "net_cash_flow_continuing": {"value": -221334000.0, "unit": "USD", "label": "Net Cash Flow, Continuing", "order": 1200}, "net_cash_flow_from_investing_activities_continuing": {"value": -29665000.0, "unit": "USD", "label": "Net Cash Flow From Investing Activities, Continuing", "order": 500}}, "comprehensive_income": {"comprehensive_income_loss_attributable_to_noncontrolling_interest": {"value": 0, "unit": "USD", "label": "Comprehensive Income/Loss Attributable To Noncontrolling Interest", "order": 200}, "comprehensive_income_loss": {"value": -281328000.0, "unit": "USD", "label": "Comprehensive Income/Loss", "order": 100}, "other_comprehensive_income_loss": {"value": -281328000.0, "unit": "USD", "label": "Other Comprehensive Income/Loss", "order": 400}, "comprehensive_income_loss_attributable_to_parent": {"value": -281328000.0, "unit": "USD", "label": "Comprehensive Income/Loss Attributable To Parent", "order": 300}}, "income_statement": {"income_tax_expense_benefit_deferred": {"value": 0, "unit": "USD", "label": "Income Tax Expense/Benefit, Deferred", "order": 2400}, "interest_expense_operating": {"value": 6273000.0, "unit": "USD", "label": "Interest Expense, Operating", "order": 2700}, "preferred_stock_dividends_and_other_adjustments": {"value": 0, "unit": "USD", "label": "Preferred Stock Dividends And Other Adjustments", "order": 3900}, "diluted_earnings_per_share": {"value": -4.17, "unit": "USD / shares", "label": "Diluted Earnings Per Share", "order": 4300}, "income_tax_expense_benefit": {"value": 0, "unit": "USD", "label": "Income Tax Expense/Benefit", "order": 2200}, "net_income_loss_attributable_to_parent": {"value": -281310000.0, "unit": "USD", "label": "Net Income/Loss Attributable To Parent", "order": 3500}, "benefits_costs_expenses": {"value": 0, "unit": "USD", "label": "Benefits Costs and Expenses", "order": 200}, "operating_income_loss": {"value": -274676000.0, "unit": "USD", "label": "Operating Income/Loss", "order": 1100}, "income_loss_from_continuing_operations_after_tax": {"value": -281310000.0, "unit": "USD", "label": "Income/Loss From Continuing Operations After Tax", "order": 1400}, "participating_securities_distributed_and_undistributed_earnings_loss_basic": {"value": 0, "unit": "USD", "label": "Participating Securities, Distributed And Undistributed Earnings/Loss, Basic", "order": 3800}, "net_income_loss": {"value": -281310000.0, "unit": "USD", "label": "Net Income/Loss", "order": 3200}, "revenues": {"value": 77798000.0, "unit": "USD", "label": "Revenues", "order": 100}, "income_tax_expense_benefit_current": {"value": 0, "unit": "USD", "label": "Income Tax Expense/Benefit, Current", "order": 2300}, "net_income_loss_attributable_to_noncontrolling_interest": {"value": 0, "unit": "USD", "label": "Net Income/Loss Attributable To Noncontrolling Interest", "order": 3300}, "net_income_loss_available_to_common_stockholders_basic": {"value": -281310000.0, "unit": "USD", "label": "Net Income/Loss Available To Common Stockholders, Basic", "order": 3700}, "costs_and_expenses": {"value": 352474000.0, "unit": "USD", "label": "Costs And Expenses", "order": 600}, "income_loss_from_continuing_operations_before_tax": {"value": 77798000.0, "unit": "USD", "label": "Income/Loss From Continuing Operations Before Tax", "order": 1500}, "operating_expenses": {"value": 352474000.0, "unit": "USD", "label": "Operating Expenses", "order": 1000}, "basic_earnings_per_share": {"value": -4.17, "unit": "USD / shares", "label": "Basic Earnings Per Share", "order": 4200}}, "balance_sheet": {"other_than_fixed_noncurrent_assets": {"value": 260385000.0, "unit": "USD", "label": "Other Than Fixed Noncurrent Assets", "order": 500}, "liabilities": {"value": 462692000.0, "unit": "USD", "label": "Liabilities", "order": 600}, "assets": {"value": 531163000.0, "unit": "USD", "label": "Assets", "order": 100}, "current_liabilities": {"value": 67289000.0, "unit": "USD", "label": "Current Liabilities", "order": 700}, "equity": {"value": 68471000.0, "unit": "USD", "label": "Equity", "order": 1400}, "noncurrent_assets": {"value": 285046000.0, "unit": "USD", "label": "Noncurrent Assets", "order": 300}, "noncurrent_liabilities": {"value": 395403000.0, "unit": "USD", "label": "Noncurrent Liabilities", "order": 800}, "current_assets": {"value": 246117000.0, "unit": "USD", "label": "Current Assets", "order": 200}, "fixed_assets": {"value": 24661000.0, "unit": "USD", "label": "Fixed Assets", "order": 400}, "liabilities_and_equity": {"value": 531163000.0, "unit": "USD", "label": "Liabilities And Equity", "order": 1900}, "equity_attributable_to_noncontrolling_interest": {"value": 0, "unit": "USD", "label": "Equity Attributable To Noncontrolling Interest", "order": 1500}, "equity_attributable_to_parent": {"value": 68471000.0, "unit": "USD", "label": "Equity Attributable To Parent", "order": 1600}}}}], "status": "OK", "request_id": "4d4b0a70bbb22e126f0513648d87dbc0"}